Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of FLIP Topography to Evaluate Esophageal Symptoms in Patients With Scleroderma

NCT03270722 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03270722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of FLIP Topography to Evaluate Esophageal Symptoms in Patients With Scleroderma
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Withdrawn
Start date
January 1, 2018
Completion date
May 31, 2020
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dysphagia, gerd - gastro-esophageal reflux disease, scleroderma